Stef Janssens
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 24
- Cardiac Fibrosis and Remodeling 21
- Physiology 42
- Nitric Oxide and Endothelin Effects 34
- Co-authors
- Kenneth D. Bloch (22 shared papers)An L. Moens (3 shared papers)Yanti Octavia (2 shared papers)Kathleen L. Gabrielson (1 shared paper)Carlo Gabriele Tocchetti (1 shared paper)Harry J.G.M. Crijns (1 shared paper)Donald B. Bloch (8 shared papers)Hilde Gillijns (46 shared papers)
- Journals
- European Heart Journal (30 papers)Circulation (29 papers)Journal of the American College of Cardiology (14 papers)European Journal of Heart Failure (13 papers)International Journal of Cardiology (7 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Stef Janssens
357 papers receiving 32.2k citations
Stef Janssens's Hit Papers
Peers
Comparison fields: 5 of 186
- Cardiology and Cardiovascular Medicine 14.8k
- Endocrinology, Diabetes and Metabolism 6.6k
- Genetics 1.4k
- Surgery 5.2k
- Nephrology 762
Countries citing papers authored by Stef Janssens
This map shows the geographic impact of Stef Janssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stef Janssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stef Janssens more than expected).
Fields of papers citing papers by Stef Janssens
This network shows the impact of papers produced by Stef Janssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stef Janssens. The network helps show where Stef Janssens may publish in the future.
Co-authors
The 25 scholars most cited alongside Stef Janssens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 369 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Hit paper breakdown → | 2021 | 9072 |
| 2 | Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Hit paper breakdown → | 2020 | 3759 |
| 3 | Empagliflozin in Heart Failure with a Preserved Ejection Fraction Hit paper breakdown → | 2021 | 3399 |
| 4 | Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Hit paper breakdown → | 2022 | 1922 |
| 5 | Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies Hit paper breakdown → | 2012 | 1176 |
| 6 | Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Hit paper breakdown → | 2006 | 1043 |
| 7 | The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial Hit paper breakdown → | 2008 | 736 |
| 8 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Hit paper breakdown → | 2022 | 670 |
| 9 | 1992 | 549 | |
| 10 | Myocardial ischemia-reperfusion injury and the influence of inflammation Hit paper breakdown → | 2022 | 361 |
| 11 | 2010 | 345 | |
| 12 | 2009 | 279 | |
| 13 | 2005 | 260 | |
| 14 | 2004 | 205 | |
| 15 | 1998 | 199 | |
| 16 | 2016 | 196 | |
| 17 | 2020 | 185 | |
| 18 | 1998 | 158 | |
| 19 | 2009 | 157 | |
| 20 | 1998 | 152 |
About Stef Janssens
Stef Janssens is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Surgery, Pulmonary and Respiratory Medicine and Genetics, having authored 369 papers that have together received 33.2k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (34 papers), Pulmonary Hypertension Research and Treatments (24 papers), Heart Failure Treatment and Management (24 papers), Tissue Engineering and Regenerative Medicine (22 papers), Cardiac Fibrosis and Remodeling (21 papers), Cardiac Ischemia and Reperfusion (21 papers), Mesenchymal stem cell research (19 papers) and Cardiac Imaging and Diagnostics (16 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (14.8k citations), Endocrinology, Diabetes and Metabolism (6.6k citations), Genetics (1.4k citations), Surgery (5.2k citations) and Nephrology (762 citations). Stef Janssens has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Kenneth D. Bloch, An L. Moens, Yanti Octavia, Kathleen L. Gabrielson, Carlo Gabriele Tocchetti, Harry J.G.M. Crijns, Donald B. Bloch, Hilde Gillijns, Akito Shimouchi and Thomas Quertermous. Their work appears in journals such as European Heart Journal, Circulation, Journal of the American College of Cardiology, European Journal of Heart Failure and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.